P482: NOVEL BISPECIFIC INNATE CELL ENGAGER AFM28 FOR THE TREATMENT OF CD123 POSITIVE ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME. (23rd June 2022) - Siegler, J.-J.; Schmitt, N.; Pahl, J.; Haneke, T.; Kozlowska, I.; Sarlang, S.; Beck, A.; Knackmuss, S.; Ravenstijn, P.; Reusch, U.; Medina-Echeverz, J.; Endell, J.; et al.